"Brimonidine Tartrate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION.
| Descriptor ID |
D000068438
|
| MeSH Number(s) |
D03.633.100.857.070
|
| Concept/Terms |
Brimonidine Tartrate- Brimonidine Tartrate
- Tartrate, Brimonidine
- 5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline D-tartrate
UK 14,304-18- UK 14,304-18
- UK 14,304 18
- UK 14,30418
- UK-14,304-18
- UK14,30418
UK 14308- UK 14308
- UK-14,308
- UK 14,308
- UK14,308
AGN 190342- AGN 190342
- 190342, AGN
- AGN-190342
- AGN190342
Brimonidine- Brimonidine
- 5-bromo-6-(imidazolidinylideneamino)quinoxaline
- 5-bromo-6-(imidazolin-2-ylamino)quinoxaline
- Bromoxidine
|
Below are MeSH descriptors whose meaning is more general than "Brimonidine Tartrate".
Below are MeSH descriptors whose meaning is more specific than "Brimonidine Tartrate".
This graph shows the total number of publications written about "Brimonidine Tartrate" by people in this website by year, and whether "Brimonidine Tartrate" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 1995 | 0 | 1 | 1 |
| 1998 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Brimonidine Tartrate" by people in Profiles.
-
Vitreous concentration of topically applied brimonidine-purite 0.15%. J Ocul Pharmacol Ther. 2006 Aug; 22(4):242-6.
-
Bilateral simultaneous anterior ischemic optic neuropathy in a young, healthy man. Arch Ophthalmol. 2003 Nov; 121(11):1652-3.
-
Pharmacological evidence of a role for prejunctional imidazoline (I(1)) receptors in ocular function. Curr Eye Res. 2002 Nov; 25(5):267-70.
-
Role of endocytosis in the activation of the extracellular signal-regulated kinase cascade by sequestering and nonsequestering G protein-coupled receptors. Proc Natl Acad Sci U S A. 2000 Feb 15; 97(4):1489-94.
-
Alpha 2-adrenergic receptor activation inhibits calcitonin gene-related peptide expression in cultured dorsal root ganglia neurons. Brain Res. 1998 Jan 26; 782(1-2):184-93.
-
Factors determining specificity of signal transduction by G-protein-coupled receptors. Regulation of signal transfer from receptor to G-protein. J Biol Chem. 1995 Jun 23; 270(25):15269-76.
-
Alpha-2 adrenoceptor mediated changes in aqueous dynamics: effect of pertussis toxin. Exp Eye Res. 1994 Jun; 58(6):729-36.
-
Pharmacological evidence for heterogeneity of ocular alpha 2 adrenoceptors. Curr Eye Res. 1992 Oct; 11(10):963-70.
-
Functional evidence for heterogeneity of ocular alpha 2-adrenoceptors. Proc West Pharmacol Soc. 1990; 33:257-60.
-
Can UK-14, 304-18 lower IOP in rabbits by a peripheral mechanism? Curr Eye Res. 1989 Jun; 8(6):547-52.